Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma
| Status: | Completed |
|---|---|
| Conditions: | Asthma |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 4 - 21 |
| Updated: | 4/17/2018 |
| Start Date: | January 1, 2016 |
| End Date: | December 31, 2017 |
This study will assess whether adaption of the Asthma Control Test (ACT) and childhood Asthma
Control Test (cACT) for mobile devices improves rate of completion and improves control of
asthma in children and adolescents
Control Test (cACT) for mobile devices improves rate of completion and improves control of
asthma in children and adolescents
Asthma is the most prevalent chronic disease of childhood with an overall prevalence of 10%.
While effective therapies exist to control symptoms and prevent exacerbations, many asthma
patients experience significant morbidity including limitations on daily activities as well
as asthma exacerbations that lead to missed school (and work for care givers) and necessitate
emergency department visits and hospitalizations. Among children from lower socioeconomic
statues and in black and Hispanic families, asthma incidence and severity are even greater.
Reasons for this disparity included decreased access to effective asthma care, increased
exposure to tobacco smoke and environmental allergens, and underutilization of controller
medicines. These groups have significantly increased resource utilization due to emergency
department visits and hospitalizations. Optimal care for asthma patients, especially those
with at highest risk, will therefore require new strategies for evaluating ongoing control
and providing direct feedback to patients.
We propose to transform the way asthma care is provided through the use of an innovative
patient centered technology -Trivox Asthma ‐ to improve quality of care and outcomes for
asthma patients while reducing the cost of care. Specifically we will extend Trivox Health to
facilitate closer monitoring of patients with asthma through the existing web platform and a
new mobile interface. This will allow asthma patients, their parents and school nurses to
remotely input data on asthma control through smartphones and/or tablets. We will use the
ACT+, an expansion of a validated measure currently utilized in both primary care and
specialty clinics, to measure both asthma control and risk.
Effectiveness of this intervention will be measured by examining resource utilization and
ongoing asthma control.
While effective therapies exist to control symptoms and prevent exacerbations, many asthma
patients experience significant morbidity including limitations on daily activities as well
as asthma exacerbations that lead to missed school (and work for care givers) and necessitate
emergency department visits and hospitalizations. Among children from lower socioeconomic
statues and in black and Hispanic families, asthma incidence and severity are even greater.
Reasons for this disparity included decreased access to effective asthma care, increased
exposure to tobacco smoke and environmental allergens, and underutilization of controller
medicines. These groups have significantly increased resource utilization due to emergency
department visits and hospitalizations. Optimal care for asthma patients, especially those
with at highest risk, will therefore require new strategies for evaluating ongoing control
and providing direct feedback to patients.
We propose to transform the way asthma care is provided through the use of an innovative
patient centered technology -Trivox Asthma ‐ to improve quality of care and outcomes for
asthma patients while reducing the cost of care. Specifically we will extend Trivox Health to
facilitate closer monitoring of patients with asthma through the existing web platform and a
new mobile interface. This will allow asthma patients, their parents and school nurses to
remotely input data on asthma control through smartphones and/or tablets. We will use the
ACT+, an expansion of a validated measure currently utilized in both primary care and
specialty clinics, to measure both asthma control and risk.
Effectiveness of this intervention will be measured by examining resource utilization and
ongoing asthma control.
Inclusion Criteria:
- Diagnosis of asthma
- Cared for at Boston Children's Hospital (Primary or secondary care)
Exclusion Criteria:
- Age <4 or >21
We found this trial at
1
site
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
Click here to add this to my saved trials
